$0.00
(0.00%
) Quote details
USD
$0.00
(0.00%
)At Close (As of Dec 11, 2025)
$600.28M
Market Cap
20.5
P/E Ratio
0.18
EPS
$5.13
52 Week High
$0.52
52 Week Low
HEALTHCARE
Sector
Sector: HEALTHCARE
Industry: DRUG MANUFACTURERS - SPECIALTY & GENERIC
Ironwood Pharmaceuticals, Inc. is a prominent biotechnology firm headquartered in Boston, Massachusetts, specializing in the development and commercialization of innovative gastroenterological therapies. The company has a strong market presence driven by its flagship product, Linzess (linaclotide), and a robust pipeline aimed at addressing significant unmet medical needs in gastrointestinal disorders. Ironwood's strategic emphasis on research, development, and partnerships enhances its therapeutic offerings and positions it for sustainable growth, promising substantial long-term value for institutional investors while ultimately improving patient outcomes.
LPTX
WOK
VSME
PETS
NVDA
VHAI
ORCL
KIND
ASST
PLUG
IRBT
ADAP
K
TSLA
INTC
F
DNN
IVP
NFLX
AAL
MTSR
PLTR
KVUE
RR
PLTD
SOFI
HOOD
MARA
RGTI
GOOGL
NIO
BITF
WBD
BYND
BTBT
CDE
ACIU
NOK
RKLB
CNQ
BAC
VALE
IREN
CAN
CCL
CIFR
GRAB
NCLH
SNAP
WULF
DVLT
PFE
SMR
SHOT
ZAPP
GOOG
QBTS
AVGO
UBER
SOUN
BLNK
KO
RIG
AMD
LPTX
WOK
VSME
PETS
NVDA
VHAI
ORCL
KIND
ASST
PLUG
IRBT
ADAP
K
TSLA
INTC
F
DNN
IVP
NFLX
AAL
MTSR
PLTR
KVUE
RR
PLTD
SOFI
HOOD
MARA
RGTI
GOOGL
NIO
BITF
WBD
BYND
BTBT
CDE
ACIU
NOK
RKLB
CNQ
BAC
VALE
IREN
CAN
CCL
CIFR
GRAB
NCLH
SNAP
WULF
DVLT
PFE
SMR
SHOT
ZAPP
GOOG
QBTS
AVGO
UBER
SOUN
BLNK
KO
RIG
AMD